WS #12007

From 500 msgs · 4 key-dev

FDA approves Biogen's LEQEMBI IQLIK subcutaneous injection for early Alzheimer's, a first-of-its-kind at-home dosing option, with US launch planned for late August 2026.

FDA Approval for Biogen Alzheimer's Drug

FDA approves Biogen's LEQEMBI IQLIK subcutaneous injection for early Alzheimer's, a first-of-its-kind at-home dosing option, with US launch planned for late August 2026.

Full world state #12007 →

FDA Approval for Biogen Alzheimer's Drug — World state #12007 · River